Other microvascular outcomes did not improve in tandem with the observed renoprotective effects of GLP1RA use, and retinopathy was observed more frequently with GLP1RA use compared to placebo in some of the CVOT trials to date (see below)
Key Takeaways Semaglutide Benefits : Effective for weight loss, especially in type 2 diabetes and obesity
In the UK, these medications are commonly prescribed for type 2 diabetes and, more recently, for chronic weight management
Clinicians link these patterns to indirect effects of weight loss medications, not to a genital specific mechanism
#LenusHealth #ObesityTreatment #WeightLoss #GLP1 #Wegovy #MetabolicHealth #DigitalHealth #PreventiveCare #SustainableHealth To view or add a comment, sign in More Relevant Posts The #UK MHRA has approved a higher 7.2 mg weekly #dose of Novo Nordisks #Wegovy for adults with obesity, offering greater weightloss potential